Article

Characterization of raloxifene as potential pharmacological agent against SARS-CoV-2 and its variants

2021-10-24

Abstract excerpt

The new coronavirus that emerged, called SARS-CoV-2, is the causative agent of the COVID-19 pandemic. The identification of potential drug candidates that can rapidly enter clinical trials for the prevention and treatment of COVID-19 is an urgent need, despite the recent introduction of several new vaccines for the prevention and protection of this infectious disease, which in many cases becomes severe. Drug repur...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5c7188e0-4cf5-5b30-962a-04d1cf83d0ab
DOI: 10.1101/2021.10.22.465294

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Characterization of raloxifene as potential pharmacological agent against SARS-CoV-2 and its variantsDOI 10.1101/2021.10.22.465294Read

Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variantsSemantic proximity Read

The COVID-19 PHARMACOME: A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonizationSemantic proximity Read

Tripartite combination of potential pandemic mitigation agents: Vitamin D, Quercetin, and Estradiol manifest properties of candidate medicinal agents for mitigation of the severity of pandemic COVID-19 defined by genomics-guided tracing of SARS-CoV-2 targets in human cells.Semantic proximity Read

17β‐estradiol reduces SARS‐CoV‐2 infection in vitroSemantic proximity Read

Estrogen Hormone Is an Essential Sex Factor Inhibiting Inflammation and Immune Response in COVID-19Semantic proximity Read

Use of Antiandrogens as Therapeutic Agents in COVID-19 PatientsSemantic proximity Read

In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2Semantic proximity Read

Targeting steroid hormone receptors for anti‐cancer therapy—A review on small molecules and nanotherapeutic approachesSemantic proximity Read

Multitarget Design of Steroidal Inhibitors Against Hormone-Dependent Breast Cancer: An Integrated In Silico ApproachSemantic proximity Read

Many small steps towards a COVID-19 drugSemantic proximity Read

Systematic Down-Selection of Repurposed Drug Candidates for COVID-19Semantic proximity Read

Structure–Activity Relationship and Biological Investigation of a REV-ERBα-Selective Agonist SR-29065 (34) for Autoimmune DisordersSemantic proximity Read